{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.189","meta":{"versionId":"6","lastUpdated":"2021-07-20T01:02:16.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.189","version":"20210720","name":"Pembrolizumab Injectable","status":"active","date":"2021-07-20T01:02:16-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1657746","display":"pembrolizumab 50 MG Injection"},{"code":"1657750","display":"4 ML pembrolizumab 25 MG/ML Injection"}]}]},"expansion":{"identifier":"urn:uuid:e89f88ae-7d08-4814-8ee9-a915a44d325c","timestamp":"2022-06-10T10:49:34-04:00","total":2,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1657746","display":"pembrolizumab 50 MG Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1657750","display":"4 ML pembrolizumab 25 MG/ML Injection"}]}}